The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Investment of cash into trust account | - | 0 | - | - |
| Net cash used in investing activities | - | 0 | - | - |
| Proceeds from issuance of class b ordinary shares to sponsor | - | 0 | - | - |
| Proceeds from sale of units, net of underwriting discounts paid | - | 0 | - | - |
| Proceeds from advances from sponsor | - | 0 | - | - |
| Repayment of advances from sponsor through the private placement proceeds | - | 0 | - | - |
| Payment of offering costs | - | 0 | - | - |
| Proceeds from sale of private placement warrants | - | 0 | - | - |
| Net cash provided by financing activities | - | 0 | - | - |
| Net income | 1,034,133 | 671,398 | 1,266,719 | 3,079,421 |
| Change in fair value of over-allotment liability | - | 0 | 0 | -26,558 |
| Interest earned on cash held in trust account | 1,548,784 | 1,722,949 | 1,860,392 | 3,604,845 |
| Prepaid insurance | - | -13,457 | -21,251 | -42,500 |
| Prepaid expenses | -24,535 | -14,733 | -24,500 | 36,000 |
| Accrued expenses | 115,234 | -52,856 | -7,500 | -13,974 |
| Deferred legal fees | -243,000 | -613,382 | -474,583 | -200,000 |
| Net cash used in operating activities | -131,882 | -462,835 | -80,839 | -359,456 |
| Net change in cash and cash equivalents | -131,882 | -462,835 | -80,839 | -359,456 |
| Cash and cash equivalents beginning of period | 544,791 | 1,007,626 | 1,447,921 | - |
| Cash and cash equivalents end of period | 412,909 | 544,791 | 1,007,626 | - |